Loading...
Induction of natural killer antibody-dependent cell cytotoxicity and of clinical activity of cetuximab plus avelumab in non-small cell lung cancer
BACKGROUND: Antibody-dependent cell-mediated cytotoxicity (ADCC) may mediate antitumour activity of IgG1-isotype monoclonal antibody (mAb), suggesting as potential treatment combination of IgG1-mAbs, anti-epidermal growth factor receptor cetuximab and anti-programmed death-ligand-1 avelumab. METHODS...
Saved in:
Published in: | ESMO Open |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , , |
Format: | Artigo |
Language: | Inglês |
Published: |
BMJ Publishing Group
2020
|
Subjects: | |
Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7484864/ https://ncbi.nlm.nih.gov/pubmed/32912860 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/esmoopen-2020-000753 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|